Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
Genomic alterations in KMT2 family predict outcome of immune checkpoint therapy in multiple cancers
Immune checkpoint therapy (ICT) can produce durable antitumor responses in various cancer types; however, the responses are not universal, and the predictive biomarkers are urgently needed. Growing evidence po...
Citation: Journal of Hematology & Oncology 2021 14:39